Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial

Publication | Open Access

DOI Full Paper Access

106

Citations

References

2020

Year

Aaron R. Weiss, Yen‐Lin Chen, Thomas J. Scharschmidt, Yueh-Yun Chi, Jing Tian, Jennifer O. Black, Jessica L. Davis, Julie C. Fanburg–Smith, Eduardo Zambrano, James R. Anderson,

The Lancet Oncology

Surgical OncologyOncologyRadiation TherapyMalignant DiseaseLarge Unresected Intermediate-gradePreoperative ChemoradiotherapyPathological ResponseCancer TreatmentMedicineRadiation OncologyCancer ResearchRadiologyHealth Sciences